Tuesday 13 October 2026
Export all NUS data to Excel Powerpack
Nu Skin Enterprises, Inc.
NUS Consumer Defensive Household & Personal Products
Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024. In the quarter to June 2026, revenue fell 17.1%, EPS fell 1,295.4%, free cash flow fell 86.1% and total debt fell 14.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.87
0.13
+2.74%
Follow NUS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 6.50 | 2.97 | 5.52 |
+8 more quarters Free account |
P/S ratio |
0.19 | 0.24 | 0.32 | 0.39 | |
P/FCF ratio |
23.80 | 8.44 | 10.31 | 11.29 | |
P/Operating CF |
24.15 | (89.54) | 28.53 | 21.91 | |
P/B ratio |
0.47 | 0.44 | 0.59 | 0.75 | |
Price to Tangible BV |
0.51 | 0.52 | 0.70 | 0.90 | |
EV/Sales |
0.20 | 0.26 | 0.31 | 0.37 | |
EV/EBITDA |
7.04 | 2.88 | 3.89 | 12.78 | |
EV/Operating CF |
5.49 | 4.92 | 5.71 | 6.46 | |
EV/FCF |
25.87 | 9.00 | 9.97 | 10.84 | |
Quick Ratio |
0.94 | 0.95 | 1.06 | 1.19 | |
Current Ratio |
1.98 | 2.03 | 2.08 | 2.15 | |
Net Debt/EBITDA |
(0.48) | 1.42 | (0.43) | (0.71) | |
Debt/Assets |
19.05% | 16.24% | 15.95% | 16.08% | |
Debt/Equity |
0.39 | 0.28 | 0.28 | 0.29 | |
Asset Turnover |
1.07 | 1.04 | 1.03 | 1.04 | |
Operating CF/Net income |
(0.04) | (2.13) | 1.15 | 1.61 | |
Capex/Depreciation |
(0.45) | (1.11) | (0.83) | (0.82) | |
Interest Coverage |
(17.86) | 0.95 | 5.82 | 5.22 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
62.09% | 65.06% | 64.47% | 64.55% | |
Intangible Assets out of Total Assets |
0.04 | 0.09 | 0.09 | 0.09 | |
Share Based Compensation of Revenue |
0.35% | 1.15% | 0.85% | 1.60% | |
Graham Net Nets |
(0.28) | (0.17) | (0.11) | (0.13) | |
Graham Number |
0.00 | 20.38 | 34.51 | 28.37 | |
Earnings Yield |
(84.28%) | 15.38% | 33.68% | 18.13% | |
Free Cash Flow Yield |
4.20% | 11.85% | 9.70% | 8.86% | |
Revenue per Share |
6.59 | 6.65 | 7.51 | 7.37 | |
Operating CF per Share |
0.22 | (0.08) | 0.34 | 0.56 | |
Capex per Share |
(0.12) | (0.28) | (0.22) | (0.20) | |
Free Cash Flow per Share |
0.10 | (0.37) | 0.12 | 0.36 | |
Cash per Share |
3.94 | 4.16 | 4.87 | 5.12 | |
Shareholders Equity per Share |
11.17 | 16.47 | 16.34 | 16.19 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.17 | 16.47 | 16.34 | 16.19 | |
Free Cash Flow |
4.99 | (17.63) | 5.86 | 17.57 | |
Working Capital |
251.80 | 265.89 | 283.96 | 293.71 | |
Capital Expenditures |
(5.64) | (13.71) | (10.76) | (9.91) | |
Net Current Asset Value |
(70.64) | (59.82) | (52.37) | (76.47) | |
EV/EBIT |
0.00 | 4.69 | 6.97 | 0.00 | |
Capex to Sales |
0.02 | 0.04 | 0.03 | 0.03 | |
Price to Operating Income |
0.00 | 4.40 | 7.21 | 0.00 | |
| Other line items | |||||
Average Receivables |
54.30 | 50.79 | 45.16 | 58.85 | |
Average Payables |
33.22 | 31.20 | 30.53 | 30.63 | |
Average Inventory |
185.94 | 183.69 | 184.44 | 213.16 | |
Average Assets |
1,282.61 | 1,384.10 | 1,437.11 | 1,503.65 | |
Average Common Equity |
665.25 | 774.03 | 728.35 | 753.33 |
Columns are period end dates